vantictumab (OMP-18R5) - Mereo Biopharma, Bayer
OncoMed: Q4 FY 2015 Results (OncoMed) - Mar 12, 2016 - Anticipated data from P1 trial (NCT02005315) for pancreatic cancer in 2016; Anticipated data from P1 trial (NCT01973309) for breast cancer in 2016 
Anticipated P1 data Breast Cancer • Oncology • Pancreatic Cancer
http://investor.shareholder.com/oncomed/releasedetail.cfm?ReleaseID=960007
 
Mar 12, 2016
 
.